One of the long rumored features that is expected to debut in a future Apple Watch is the ability to measure blood sugar stages without needles. This is expected to be a huge deal and would be perfect for people with diabetes who might need to keep a close gaze on their blood sugar elevations throughout the day.
However, it seems that a Japanese company by the called of Quantum Operation Inc. has been possible to beaten Apple to the punch. They have debuted a example wearable that they claim “re capable of” a noninvasive route of measurement of the wearer’s blood sugar tiers through a spectrometer that examines the blood to step glucose.
According to the company, the secret to their technology is the choice of materials used to build the machine. The busines hopes that they will be able to sell their technology to insurance and healthcare providers, although based on readings comparison with a finger-prick monitor, the FreeStyle Libre, there are noticeable variations.
This means that for consumers who need a more accurate reading to adjust their insulin stages, Quantum Operation’s current paradigm might not cut it. Nonetheless, as with medical tech built into wearables like a heart rate monitor and ECG monitor, these tools aren’t consequently designed to be decisive, and for the most part, companionships like Apple still recommend that users seek professional medical advice.
Read more: ubergizmo.com